High-dose moxalactam in gram-negative pneumonia: efficacy and safety.

D. K. Payne, L. E. Vereen, R. B. George, J. R. Lentino, J. P. O'Keefe, F. R. Venezio, J. Rotschafer

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)293-295
Number of pages3
JournalDrug intelligence & clinical pharmacy
Issue number3
StatePublished - Mar 1987

Cite this